A Very Merry Verdict for Dean Omar Branham Shirley LLC
A Minnesota jury’s $65.5 million verdict against Johnson & Johnson landed with unmistakable force, the culmination of a trial that centered not on abstract corporate conduct, but on the lived reality of Anna Jean Houghton Carley, a young Minnesota mother confronting a devastating diagnosis. For decades, Carley had used Johnson & Johnson’s talcum-based Baby Powder, beginning in childhood and continuing into adulthood, trusting a product marketed as gentle, safe, and pure. That trust, her attorneys argued, came at a catastrophic cost.
Carley was diagnosed with mesothelioma, a rare and aggressive cancer most commonly linked to asbestos exposure. At trial, her legal team contended that Johnson & Johnson knew for years that talc could be contaminated with asbestos but failed to warn consumers, instead continuing to promote the product as safe for daily use. Over nearly two weeks of testimony, jurors heard evidence tracing Carley’s exposure back to the powder she had used throughout her life — exposure that experts said was consistent with her illness.
Carley was represented by Ben Braly of Dean Omar Branham Shirley LLP, who framed the case as one of accountability. His team emphasized internal company documents, scientific testimony, and the human stakes behind the litigation, urging jurors to see the verdict as a measure of responsibility rather than mere compensation. The jury ultimately agreed, awarding $65.5 million to reflect the profound physical suffering, emotional trauma, and future losses tied to Carley’s diagnosis.
Johnson & Johnson mounted a firm defense, disputing the claim that its talc products contained asbestos or caused cancer. The company’s litigation response was led by Erik Haas, Worldwide Vice President of Litigation for Johnson & Johnson, who maintained that decades of testing have shown the products to be safe. Following the verdict, Johnson & Johnson announced its intention to appeal, asserting confidence that the decision will not withstand appellate review.
Still, the verdict adds to the growing legal reckoning facing Johnson & Johnson in talc litigation nationwide. For Carley and her legal team, the decision represents more than a monetary award — it stands as a public acknowledgment of harm and a clear message that juries are prepared to scrutinize corporate assurances when consumer safety is on the line.
This Med-Mal Case Finally Ends, it’s a Christmas Miracle!
After years of litigation that included multiple trial rounds and strategic defense delays, a Fulton County (Georgia) jury has awarded $48 million in a medical malpractice lawsuit brought by the family of Vietnam combat veteran Tony Waldrop. The verdict, returned in December 2025, came after jurors concluded that dermatologist Dr. Joseph R. Payne, M.D., and Dermatology Associates of Atlanta, P.C. failed to properly diagnose and treat recurrent skin cancer, ultimately leading to catastrophic injury and disfigurement.
The case of Waldrop v. Payne began in 2017, but did not reach a final verdict until December 2025 due to a series of litigation setbacks. The first scheduled trial in 2020 ended in a mistrial shortly after opening statements, and a retrial in January 2024 resulted in a defense verdict. However, the judge granted a motion for a new trial due to evidentiary issues in the 2024 proceeding, paving the way for the eventual December 2025 trial and verdict.
Lead counsel for the plaintiffs were Lloyd Bell of Bell Law Firm, Laura Shamp of Shamp Silk, and Darren Summerville of The Summerville Firm. They argued that Dr. Payne’s treatment fell below the accepted standard of care by failing to refer Waldrop for oncology consultation after a 2013 Mohs surgery revealed high-risk features of the tumor and by misdiagnosing a subsequent lesion as benign without biopsy. These lapses, plaintiff lawyers contended, allowed the aggressive cancer to advance, resulting in the loss of most of Waldrop’s right ear, permanent facial paralysis, loss of hearing, difficulty eating and speaking, chronic pain, and profound disfigurement.
Defense counsel from Huff Powell Bailey maintained that Dr. Payne complied with the standard of care and noted that previous juries failed to find negligence. After the verdict, defense attorneys expressed surprise at the outcome given the different jury compositions in prior trials.
The $48 million award includes $32 million for pain and suffering and $16 million for loss of consortium to Waldrop’s wife, Patricia Worley. Throughout the extended litigation, the defense’s insurance carrier offered a $2 million settlement — far less than the verdict — and the trial underscored the challenges plaintiffs often face when cases stretch over many years with repeated procedural hurdles.
Plaintiffs and their attorneys have highlighted that the drawn-out process, multiple trials, and repeated delays imposed emotional strain and additional costs on the Waldrop family, making the final verdict a hard-fought vindication of their claims.
